Skip to main content
Year archive

AFT Pharmaceuticals Limited — 2023 filings

All 27 regulatory filings released by AFT Pharmaceuticals Limited (AFT) in 2023, sourced directly from the official regulator.

27 Filings
2023 Period
2023 filings (27)
Filing Released Lang
AFT broadens R&D pipeline with new product candidate
Regulatory Filings
2023-12-21 English
AFT Pharma reports growth and global expansion
Interim / Quarterly Report
2023-11-22 English
AFT’s Crystaderm(R) antiseptic approved for sale in China
Regulatory Filings
2023-11-20 English
AFT welcomes US FDA approval for sale of Maxigesic IV
Regulatory Filings
2023-10-17 English
AFT to announce half year interim results on Thurs Nov 23
Report Publication Announcement
2023-10-08 English
Retirement of Jon Lamb
Board/Management Information
2023-09-28 English
AFT appoints Andrew Lane as independent director
Board/Management Information
2023-09-28 English
Shareholder interests
Director's Dealing
2023-09-17 English
AFT Orphan Pharmaceuticals judgment
Legal Proceedings Report
2023-08-28 English
Results of 2023 Annual Shareholder Meeting
Declaration of Voting Results & Voting Rights Announcements
2023-08-04 English
Jon Lamb intention to retire
Board/Management Information
2023-08-03 English
ASM chair address and presentation
AGM Information
2023-08-03 English
AFT signs new licensing agreement for ZENEO(R) Midazolam
Capital/Financing Update
2023-07-21 English
AFT extends e-commerce presence into Amazon US
Regulatory Filings
2023-07-10 English
Notice of Annual Meeting of Shareholders 2023
AGM Information
2023-06-29 English
Annual Meeting and Closing Date for Director Nominations
AGM Information
2023-05-26 English
NOTICE PURSUANT TO LISTING RULE 7.12.1
Share Issue/Capital Change
2023-05-21 English
Distribution Notice
Notice of Dividend Amount
2023-05-21 English
AFT declares maiden dividend; record revenue
Governance Information
2023-05-21 English
AFT Pharmaceuticals to announce full year results on Monday
Report Publication Announcement
2023-05-03 English
US FDA sets PDUFA date for Maxigesic IV
Regulatory Filings
2023-04-30 English
AFT submits Maxigesic IV(R) packaging data to the US FDA
Regulatory Filings
2023-04-17 English
AFT Crystawash reg’n in China and new licencing agreements
Capital/Financing Update
2023-03-26 English
Maxigesic Rapid tablets gain US FDA approval
Regulatory Filings
2023-03-01 English
AFT to develop antibiotic eye drop
Capital/Financing Update
2023-02-01 English
AFT announces Maxigesic IV(R) distribution agreement for nine
Regulatory Filings
2023-01-23 English
2023 New Year letter to investors
Management Reports
2023-01-08 English